TYK Medicines Receives CSRC Filing Notice for H Share Full Circulation Application
I'm PortAI, I can summarize articles.
TYK Medicines Inc. has received a filing notice from the China Securities Regulatory Commission (CSRC) for its H Share Full Circulation application, valid for 12 months post-approval. The implementation plan details are pending and will be disclosed as required. The process is also subject to further procedures by the Hong Kong Stock Exchange and other regulatory bodies.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments